{
  "document": "Foundation_23",
  "Genomic Findings": [
    { "Name": "CDK4 amplification", "Clinical": [], "No Clinical": [] },
    { "Name": "KRAS amplification", "Clinical": [], "No Clinical": [] },
    { "Name": "MDM2 amplification", "Clinical": [], "No Clinical": [] },
    { "Name": "TET2 S42S424f4fs*3s*3", "Clinical": [], "No Clinical": [] },
    { "Name": "ALK", "Clinical": [], "No Clinical": [] },
    { "Name": "BRAF", "Clinical": [], "No Clinical": [] },
    { "Name": "EGFR", "Clinical": [], "No Clinical": [] },
    { "Name": "ERBB2", "Clinical": [], "No Clinical": [] },
    { "Name": "RET", "Clinical": [], "No Clinical": [] },
    { "Name": "ROS1", "Clinical": [], "No Clinical": [] }
  ],
  "Biomakers findings": [
    {
      "Name": "Tumor Mutational Burden - 11 Muts/Mb",
      "Clinical": [
        "Atezolizumab",
        "Cemiplimab",
        "Durvalumab",
        "Nivolumab",
        "Nivolumab + Ipilimumab",
        "Pembrolizumab",
        "Dostarlimab"
      ],
      "No Clinical": ["Avelumab"]
    },
    {
      "Name": "Microsatellite status - MS-Stable",
      "Clinical": [],
      "No Clinical": []
    }
  ]
}
